CFO’s Zero‑Cost Option Buy Signals Strong Insider Confidence at aTyr Pharma
Discover why aTyr Pharma’s CFO buying 412,500 zero‑cost stock options signals long‑term confidence, the risks for investors, and what it means for the company’s future.
3 minutes to read
